Xuanzhu Biopharmaceutical Co., Ltd.

Research Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK) on Bullrun: market cap HKD 4.29B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker2575.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyHKD
Market capHKD 4.29B
Financial periodFY2025
RevenueCNY 51.77M
Net income-CNY 245.51M
Free cash flow-CNY 252.52M
Gross margin64.5%

Valuation Snapshot

latest market cap is HKD 4.29B.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 51.77M	-CNY 245.51M	-CNY 252.52M	64.5%	-0.53	CNY 652.23M	CNY 647.00K	CNY 1.37B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 4.29B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Xuanzhu Biopharmaceutical Co., Ltd.

Xuanzhu Biopharmaceutical Co., Ltd. engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China. Its lead product candidates include Core- KBP-3571 for the treatment of duodenal ulcer, adult reflux esophagitis, pylori eradication; XZP-3287, a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer, R+/HER2- locally advanced or metastatic breast cancer, and adjuvant therapy for HR+/HER2- early breast cancer;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ) Yunnan Baiyao Group Co., Ltd. (000538.SZ) Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) Chang Chun High and New Technology Industry (Group) Inc. (000661.SZ) Apeloa Pharmaceutical Co., Ltd. (000739.SZ) Huadong Medicine Co Ltd (000963.SZ) China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999.SZ) Zhejiang NHU Co Ltd (002001.SZ) Jiangsu Nhwa Pharmaceutical Co Ltd (002262.SZ) Shijiazhuang Yiling Pharmaceutical Co Ltd (002603.SZ) Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)

Frequently asked questions

What is Xuanzhu Biopharmaceutical Co., Ltd.'s market cap?

Xuanzhu Biopharmaceutical Co., Ltd.'s market capitalization is HKD 4.29B.

What does Xuanzhu Biopharmaceutical Co., Ltd. do?

Xuanzhu Biopharmaceutical Co., Ltd. engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China.